Trials / Sponsors / Anbogen Therapeutics, Inc.
Anbogen Therapeutics, Inc.
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC) | Phase 1 / Phase 2 | 2025-11-01 |
| Recruiting | Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients Advanced Solid Tumor, Non Small Cell Lung Cancer, HER2 Mutations | Phase 1 / Phase 2 | 2022-09-27 |